StockSelector.com
  Research, Select, & Monitor Friday, April 03, 2020 4:40:54 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Nabriva Therapeutics AG$0.53($.08)(12.93%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Nabriva Therapeutics AG has an overall rank of 7162 out of 7217 stocks based on 7 positive rankings and 9 negative rankings.

Positive Rankings
Estimated Revenue Growth
Nabriva Therapeutics AG rank is 55
Low Put/Call
Nabriva Therapeutics AG has a low Put/Call ratio of 0.02 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Nabriva Therapeutics AG is ranked 81.
Oversold Stochastics
Nabriva Therapeutics AG rank is 380
Oversold RSI
The 14 Day Relative-Strength Index for Nabriva Therapeutics AG is 29.4. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Nabriva Therapeutics AG is ranked 513.
Up EPS Surprise
Nabriva Therapeutics AG beat the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
Nabriva Therapeutics AG rank is 2126
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Nabriva Therapeutics AG is ranked 3353.
Negative Rankings
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Nabriva Therapeutics AG is ranked 80.
Price-to-Sales
Nabriva Therapeutics AG rank is 106
Negative ROE
Nabriva Therapeutics AG rank is 135
Negative Net Margin
Nabriva Therapeutics AG rank is 155
Negative ROA
Nabriva Therapeutics AG rank is 192
Price-to-Book
Nabriva Therapeutics AG rank is 207
90 Day Loss
Nabriva Therapeutics AG rank is 347
High vPut/Call
Nabriva Therapeutics AG has a high Put/Call ratio of 2.20 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Nabriva Therapeutics AG is ranked 590.
10 Day Loss
Nabriva Therapeutics AG rank is 961







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.